Published in Neurology on September 26, 2000
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol (2011) 1.86
Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology (2008) 1.56
Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2012) 1.43
Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet (2006) 1.28
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain (2012) 1.24
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol (2009) 1.21
Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol (2014) 1.19
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain (2009) 1.13
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol (2007) 1.12
Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD? BMC Neurol (2006) 1.06
Creutzfeldt-Jacob Disease: a case report. Cases J (2008) 1.05
14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol (2012) 1.05
Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol (2006) 1.02
Case series of probable sporadic Creutzfeldt-Jakob disease from Eastern India. Ann Indian Acad Neurol (2013) 0.98
Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD. BMC Neurol (2006) 0.98
Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics (2005) 0.98
Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry (2010) 0.91
Epidemiological characteristics of human prion diseases. Infect Dis Poverty (2016) 0.89
A study of clinical profile, radiological and electroencephalographic characteristics of suspected Creutzfeldt-Jakob disease in a tertiary care centre in South India. J Neurosci Rural Pract (2015) 0.88
A proposal of new diagnostic pathway for fatal familial insomnia. J Neurol Neurosurg Psychiatry (2013) 0.87
Novel mutation of the PRNP gene of a clinical CJD case. BMC Infect Dis (2006) 0.86
The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease. PLoS One (2010) 0.85
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. Int J Mol Sci (2011) 0.84
Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics. Eur J Epidemiol (2007) 0.84
Prion disease: diagnostic value of cerebrospinal fluid markers. Nat Rev Neurol (2012) 0.83
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis. J Neuroinflammation (2014) 0.81
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD. J Neurol (2015) 0.80
Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium. Eur J Epidemiol (2006) 0.80
First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol (2014) 0.80
Multitracer PET imaging in Heidenhain variant of Creutzfeldt-Jakob disease. J Neurol (2005) 0.79
Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health (2006) 0.79
Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol (2015) 0.79
Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease. Can J Neurol Sci (2012) 0.79
Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: a case report and review of the literature. Brain Behav (2012) 0.79
Chinese specific characteristics of sporadic Creutzfeldt-Jakob disease: a retrospective analysis of 57 cases. PLoS One (2013) 0.79
Can prion disease suspicion be supported earlier? Clinical, radiological and laboratory findings in a series of cases. Prion (2011) 0.78
Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene. J Neurol (2013) 0.78
14-3-3s are potential biomarkers for HIV-related neurodegeneration. J Neurovirol (2012) 0.78
Creutzfeldt-Jakob disease versus anti-LGI1 limbic encephalitis in a patient with progressive cognitive dysfunction, psychiatric symptoms, involuntary facio-brachio-crural movement, and an abnormal electroencephalogram: a case report. Neuropsychiatr Dis Treat (2015) 0.77
14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol (2002) 0.77
Late-in-life surgery associated with Creutzfeldt-Jakob disease: a methodological outline for evidence-based guidance. Emerg Themes Epidemiol (2013) 0.77
Comparative peptidome analyses of the profiles of the peptides ranging from 1-10 KD in CSF samples pooled from probable sporadic CJD and non-CJD patients. Prion (2012) 0.76
Use of laboratory and imaging investigations in dementia. J Neurol Neurosurg Psychiatry (2005) 0.76
An unusual case of sporadic Creutzfeldt-Jakob disease (CJD). BMJ Case Rep (2010) 0.75
Quantitative EEG parameters correlate with the progression of human prion diseases. J Neurol Neurosurg Psychiatry (2016) 0.75
Neuroimaging in human prion disease: Searching in the mist. World J Radiol (2009) 0.75
Case 8: absentminded and "walking like a drunk". MedGenMed (2005) 0.75
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2001) 0.75
Prion diseases: immunotargets and therapy. Immunotargets Ther (2016) 0.75
Diagnosing sporadic creutzfeldt-jakob disease in a patient with a suspected status epilepticus in the intensive care unit. Case Rep Neurol Med (2013) 0.75
Re: Creutzfeldt-Jacob disease misdiagnosed as dementia with Lewy bodies. J Neurol (2006) 0.75
Doxycycline in early CJD: a double-blinded randomised phase II and observational study. J Neurol Neurosurg Psychiatry (2016) 0.75
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Acta Neuropathol (2017) 0.75
The value of magnetic resonance imaging in the early diagnosis of Creutzfeldt-Jakob disease - own experience. Pol J Radiol (2012) 0.75
Creutzfeldt-Jakob disease: case discussion and imaging review. Proc (Bayl Univ Med Cent) (2009) 0.75
Magnetic resonance imaging findings in probable Creutzfeld-Jacob disease: comparison with electroencephalography and cerebrospinal fluid characteristics. Acta Radiol Short Rep (2014) 0.75
Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients. Aging (Albany NY) (2016) 0.75
Creutzfeldt-Jakob Disease in a Tertiary Care Hospital in Thailand: A Case Series and Review of the Literature. J Mov Disord (2015) 0.75
Prions: Beyond a Single Protein. Clin Microbiol Rev (2016) 0.75
Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey. Noro Psikiyatr Ars (2013) 0.75
Prion disease: Brain MRI studies in prion disease. Nat Rev Neurol (2010) 0.75
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 7.84
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature (1982) 6.11
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet (1997) 5.54
Influence of cultural conditions and mutations on the composition of the outer membrane proteins of Escherichia coli. Mol Gen Genet (1976) 5.45
Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet (2000) 5.42
Ecological forecasts: an emerging imperative. Science (2001) 5.18
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet (2004) 4.85
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A (1987) 4.66
Quality of life measures in health care. I: Applications and issues in assessment. BMJ (1992) 4.53
Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet (1997) 4.38
The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet (1994) 4.15
"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet (1992) 3.74
Parental monitoring and peer influences on adolescent substance use. Pediatrics (1994) 3.66
Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet (1999) 3.39
An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature (1987) 3.33
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res (1989) 3.10
Signal transduction through prion protein. Science (2000) 3.09
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron (1998) 3.08
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Creutzfeldt-Jakob disease and blood transfusion. Lancet (1993) 2.97
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (2000) 2.92
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology (1996) 2.74
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol (1985) 2.72
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry (1984) 2.68
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis (2001) 2.62
Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1999) 2.55
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron (1996) 2.47
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol (2000) 2.42
Characterization of the mRNA for herpes simplex virus thymidine kinase by cell-free synthesis of active enzyme. Nucleic Acids Res (1978) 2.40
Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev (1994) 2.39
Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem (2000) 2.36
Granulomatous mastitis: a report of seven cases. J Clin Pathol (1982) 2.35
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol (1998) 2.35
Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol (1995) 2.34
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) (1994) 2.33
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry (2010) 2.29
The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br J Dermatol (1990) 2.22
Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol (1991) 2.20
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus. Neurology (2010) 2.17
Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology (2004) 2.15
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ (1998) 2.15
Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1982) 2.15
Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer (2001) 2.11
Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature (1992) 2.11
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol (2000) 2.04
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1986) 2.01
A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol (1999) 1.98
Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet (2001) 1.97
International differences in survival from colon cancer: more effective care versus less complete cancer registration. Br J Surg (1998) 1.97
Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ (1994) 1.97
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet (1996) 1.91
beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J Biol Chem (2001) 1.89
In vitro suppression of UAG and UGA mutants in the thymidine kinase gene of herpes simplex virus. Proc Natl Acad Sci U S A (1979) 1.88
Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand (2008) 1.88
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88